These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 12605395)

  • 1. Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
    Hussain K; Mazza JJ; Clouse LH
    Am J Hematol; 2003 Mar; 72(3):212-5. PubMed ID: 12605395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
    Baeksgaard L; Sørensen JB
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute tumour lysis syndrome after oral fludarabine in a patient with chronic lymphocytic leukaemia.
    Ramachandran A; Majumdar G
    Hematol J; 2004; 5(6):528-9. PubMed ID: 15570297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia.
    Cheson BD; Frame JN; Vena D; Quashu N; Sorensen JM
    J Clin Oncol; 1998 Jul; 16(7):2313-20. PubMed ID: 9667245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute tumor lysis syndrome during oral fludarabine treatment for chronic lymphocytic leukemia. Role of treatment with rasburicase.
    Calvo-Villas JM; Urcuyo BM; Umpierrez AM; Sicilia F
    Onkologie; 2008 Apr; 31(4):197-9. PubMed ID: 18418022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
    Rioufol C; Coiffier B
    Onkologie; 2008 Apr; 31(4):157-8. PubMed ID: 18418014
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
    Dizdar O; Yürekli BS; Pürnak T; Aksu S; Haznedaroglu IC
    Ann Pharmacother; 2004; 38(7-8):1319-20. PubMed ID: 15138295
    [No Abstract]   [Full Text] [Related]  

  • 8. Fludarabine and acute tumor lysis in chronic lymphocytic leukemia.
    Frame JN; Dahut WL; Crowley S
    N Engl J Med; 1992 Nov; 327(19):1396-7. PubMed ID: 1406856
    [No Abstract]   [Full Text] [Related]  

  • 9. Etiology and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia.
    Cheson BD
    Clin Adv Hematol Oncol; 2009 Apr; 7(4):263-71. PubMed ID: 19521331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute tumor lysis syndrome complicating fludarabine treatment of prolymphocytic leukemia.
    Cannon LM; Spilove L; Rhodes R; Garfinkel H; Pezzimenti J
    Conn Med; 1993 Oct; 57(10):651-4. PubMed ID: 8275684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor lysis syndrome following chlorambucil therapy for chronic lymphocytic leukemia: case report and review of the literature.
    Kosseifi SG; Vyas B; Vyas H; Krishnaswamy G; Smith S
    Tenn Med; 2009 Oct; 102(10):33-6. PubMed ID: 19899317
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase.
    Hummel M; Buchheidt D; Reiter S; Bergmann J; Adam K; Hehlmann R
    Eur J Haematol; 2005 Dec; 75(6):518-21. PubMed ID: 16313266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study.
    Martell RE; Peterson BL; Cohen HJ; Petros WP; Rai KR; Morrison VA; Elias L; Shepherd L; Hines J; Larson RA; Schiffer CA; Hurwitz HI
    Cancer Chemother Pharmacol; 2002 Jul; 50(1):37-45. PubMed ID: 12111110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].
    Takei K; Horikoshi A; Hosokawa Y; Sawada S; Horie T
    Rinsho Ketsueki; 2002 Nov; 43(11):993-7. PubMed ID: 12508485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fludarabine-induced eosinophilia: case report.
    Voutsadakis IA
    Ann Hematol; 2002 May; 81(5):292-3. PubMed ID: 12029541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia.
    Tsimberidou AM; Keating MJ; Giles FJ; Wierda WG; Ferrajoli A; Lerner S; Beran M; Andreeff M; Kantarjian HM; O'Brien S
    Cancer; 2004 Jun; 100(12):2583-91. PubMed ID: 15197800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
    Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
    Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyurea and splenic irradiation-induced tumour lysis syndrome: a case report and review of the literature.
    Chen SW; Hwang WS; Tsao CJ; Liu HS; Huang GC
    J Clin Pharm Ther; 2005 Dec; 30(6):623-5. PubMed ID: 16336296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.
    Lam CC; Ma ES; Kwong YL
    Am J Hematol; 2005 Aug; 79(4):288-90. PubMed ID: 16044456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of tumor lysis syndrome.
    Rampello E; Fricia T; Malaguarnera M
    Nat Clin Pract Oncol; 2006 Aug; 3(8):438-47. PubMed ID: 16894389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.